Michael A. Stashko

2.3k total citations
51 papers, 1.5k citations indexed

About

Michael A. Stashko is a scholar working on Immunology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michael A. Stashko has authored 51 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 21 papers in Molecular Biology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michael A. Stashko's work include Phagocytosis and Immune Regulation (21 papers), Receptor Mechanisms and Signaling (6 papers) and Protein Kinase Regulation and GTPase Signaling (5 papers). Michael A. Stashko is often cited by papers focused on Phagocytosis and Immune Regulation (21 papers), Receptor Mechanisms and Signaling (6 papers) and Protein Kinase Regulation and GTPase Signaling (5 papers). Michael A. Stashko collaborates with scholars based in United States, United Kingdom and Germany. Michael A. Stashko's co-authors include Stephen V. Frye, Xiaodong Wang, Dmitri Kireev, Thomas Lübben, James M. Trevillyan, Douglas K. Graham, Deborah DeRyckere, H. Shelton Earp, Zhonghua Pei and William P. Janzen and has published in prestigious journals such as Journal of the American Chemical Society, Neuron and Blood.

In The Last Decade

Michael A. Stashko

46 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael A. Stashko United States 23 708 491 340 166 160 51 1.5k
Zhulun Wang United States 17 1.2k 1.7× 297 0.6× 216 0.6× 154 0.9× 183 1.1× 27 2.0k
Xiaoshan Min United States 22 1.3k 1.8× 220 0.4× 206 0.6× 111 0.7× 199 1.2× 34 2.0k
Haoda Xu United States 10 911 1.3× 468 1.0× 208 0.6× 443 2.7× 115 0.7× 16 1.6k
Lenka Munoz Australia 20 1.0k 1.4× 257 0.5× 184 0.5× 165 1.0× 369 2.3× 38 2.0k
Tjeerd Barf Netherlands 19 724 1.0× 156 0.3× 360 1.1× 267 1.6× 229 1.4× 33 1.7k
Allan S. Wagman United States 17 1.4k 1.9× 196 0.4× 447 1.3× 106 0.6× 285 1.8× 28 2.2k
Sandra E. Wilkinson United Kingdom 20 1.6k 2.3× 530 1.1× 287 0.8× 305 1.8× 368 2.3× 34 2.7k
Greg J. Reinhart United States 17 878 1.2× 156 0.3× 207 0.6× 330 2.0× 148 0.9× 29 1.3k
Tomohiro Kawamoto Japan 24 1.1k 1.6× 243 0.5× 473 1.4× 57 0.3× 301 1.9× 61 1.9k
D. Vidović United States 15 822 1.2× 341 0.7× 84 0.2× 67 0.4× 160 1.0× 28 1.4k

Countries citing papers authored by Michael A. Stashko

Since Specialization
Citations

This map shows the geographic impact of Michael A. Stashko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Stashko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Stashko more than expected).

Fields of papers citing papers by Michael A. Stashko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Stashko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Stashko. The network helps show where Michael A. Stashko may publish in the future.

Co-authorship network of co-authors of Michael A. Stashko

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Stashko. A scholar is included among the top collaborators of Michael A. Stashko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Stashko. Michael A. Stashko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kong, Deyu, Jichen Zhao, Michael A. Stashko, et al.. (2025). Discovery of Novel TYRO3/MERTK Dual Inhibitors. Journal of Medicinal Chemistry. 68(8). 8455–8470.
2.
Zhou, Yubai, Desmarini Desmarini, Michael A. Stashko, et al.. (2025). Design, Synthesis, and Cellular Characterization of a New Class of IPMK Kinase Inhibitors. Journal of Medicinal Chemistry. 68(15). 15446–15460. 1 indexed citations
3.
Kong, Deyu, Dan Yan, Michael A. Stashko, et al.. (2025). UNC9426, a Potent and Orally Bioavailable TYRO3-Specific Inhibitor. Journal of Medicinal Chemistry. 68(6). 6665–6682.
4.
Zhou, Yubai, Molee Chakraborty, Chunfang Gu, et al.. (2022). Development of Novel IP6K Inhibitors for the Treatment of Obesity and Obesity-Induced Metabolic Dysfunctions. Journal of Medicinal Chemistry. 65(9). 6869–6887. 21 indexed citations
5.
Wang, Li, Yubai Zhou, Xuedan Wu, et al.. (2022). The Synthesis and Initial Evaluation of MerTK Targeted PET Agents. Molecules. 27(5). 1460–1460.
6.
Hoque, Monira, Ariadna Recasens, Ramzi H. Abbassi, et al.. (2021). MerTK activity is not necessary for the proliferation of glioblastoma stem cells. Biochemical Pharmacology. 186. 114437–114437. 3 indexed citations
7.
Zheng, Hongchao, Jichen Zhao, Bing Li, et al.. (2021). UNC5293, a potent, orally available and highly MERTK-selective inhibitor. European Journal of Medicinal Chemistry. 220. 113534–113534. 8 indexed citations
8.
Stashko, Michael A., Huanchen Wang, Vikas Tyagi, et al.. (2018). Use of Protein Kinase–Focused Compound Libraries for the Discovery of New Inositol Phosphate Kinase Inhibitors. SLAS DISCOVERY. 23(9). 982–988. 18 indexed citations
9.
Minson, Katherine A., Catherine C. Smith, Deborah DeRyckere, et al.. (2016). The MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia. JCI Insight. 1(3). e85630–e85630. 61 indexed citations
10.
Wang, Xiaodong, Jing Liu, Weihe Zhang, et al.. (2016). Design and Synthesis of Novel Macrocyclic Mer Tyrosine Kinase Inhibitors. ACS Medicinal Chemistry Letters. 7(12). 1044–1049. 24 indexed citations
11.
Stashko, Michael A., et al.. (2015). Discovery of Mer kinase inhibitors by virtual screening using Structural Protein–Ligand Interaction Fingerprints. Bioorganic & Medicinal Chemistry. 23(5). 1096–1101. 8 indexed citations
12.
Liu, Jing, Weihe Zhang, Michael A. Stashko, et al.. (2013). UNC1062, a new and potent Mer inhibitor. European Journal of Medicinal Chemistry. 65. 83–93. 55 indexed citations
13.
Zhang, Weihe, Dehui� Zhang, Michael A. Stashko, et al.. (2013). Pseudo-Cyclization through Intramolecular Hydrogen Bond Enables Discovery of Pyridine Substituted Pyrimidines as New Mer Kinase Inhibitors. Journal of Medicinal Chemistry. 56(23). 9683–9692. 55 indexed citations
14.
Zhang, Weihe, Andrew L. McIver, Michael A. Stashko, et al.. (2013). Discovery of Mer Specific Tyrosine Kinase Inhibitors for the Treatment and Prevention of Thrombosis. Journal of Medicinal Chemistry. 56(23). 9693–9700. 40 indexed citations
15.
Xin, Zhili, Gang Liu, Cele Abad‐Zapatero, et al.. (2003). Identification of a monoacid-Based, cell permeable, selective inhibitor of protein tyrosine phosphatase 1B. Bioorganic & Medicinal Chemistry Letters. 13(22). 3947–3950. 52 indexed citations
16.
Coghlan, Michael J., Philip R. Kym, Steven W. Elmore, et al.. (2001). Synthesis and Characterization of Non-Steroidal Ligands for the Glucocorticoid Receptor:  Selective Quinoline Derivatives with Prednisolone-Equivalent Functional Activity. Journal of Medicinal Chemistry. 44(18). 2879–2885. 78 indexed citations
17.
Shiosaki, Kazumi, Chun Wel Lin, Hana Kopecka, et al.. (1997). Minor Structural Differences in Boc-CCK-4 Derivatives Dictate Affinity and Selectivity for CCK-A and CCK-B Receptors. Journal of Medicinal Chemistry. 40(7). 1169–1172. 2 indexed citations
18.
Lin, Chii‐Wann, David G. Witte, Benedetta Bianchi, et al.. (1995). Characterization of cloned human dopamine D1 receptor-mediated calcium release in 293 cells.. Molecular Pharmacology. 47(1). 131–139. 36 indexed citations
19.
Bennett, Michael J., Arthur L. Nikkel, Thomas R. Miller, et al.. (1994). CCK-A-Selective Tetrapeptides Containing Lys(N.epsilon.)-Amide Residues: Favorable in vivo and in vitro Effects of N-Methylation at the Aspartyl Residue. Journal of Medicinal Chemistry. 37(11). 1569–1571. 1 indexed citations
20.
Shiosaki, Kazumi, Chun Wel Lin, Hana Kopecka, et al.. (1992). Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N.epsilon.)-amide residues. Journal of Medicinal Chemistry. 35(11). 2007–2014. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhulun Wang Breakdown of academic impact, for papers by Xiaoshan Min Breakdown of academic impact, for papers by Haoda Xu Breakdown of academic impact, for papers by Lenka Munoz Breakdown of academic impact, for papers by Tjeerd Barf Breakdown of academic impact, for papers by Allan S. Wagman Breakdown of academic impact, for papers by Sandra E. Wilkinson Breakdown of academic impact, for papers by Greg J. Reinhart Breakdown of academic impact, for papers by Tomohiro Kawamoto Breakdown of academic impact, for papers by D. Vidović
Rankless by CCL
2026